NewsRx

Search our medical news database

Regulatory Actions

HemoSense Satisfies FDA Concerns and Completes ISO Audit

Published in Lab Law Weekly, April 27th, 2007

HemoSense, Inc. (AMEX:HEM) announced it has received acknowledgement from the U.S. Food and Drug Administration (FDA) that the Company has satisfactorily addressed the concerns about its quality management system detailed in a Warning Letter from the FDA in November 2006. The Company also announced it has successfully completed its first ISO 13485:2003 inspection audit. ISO 13485:2003 is the internationally recognized standard for medical device development and manufacturing, which the Company first achieved in 2006.

"Our commitment to maintaining world-class design, manufacturing and quality management systems to provide superior products to our customers is...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook